Rubicon Research Limited (NSE:RUBICON)
India · Delayed Price · Currency is INR 965.50
-11.05 (-1.13%)
At close: May 5, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 165.06 billion as of May 6, 2026.
Market Cap
165.06B
Enterprise Value
169.22B
Revenue
15.98B
Ranking
n/a
PE Ratio
76.86
Stock Price
965.50
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 165.06B, an increase of 59.48%. That is a compound annual growth rate of 133.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 159.07B | 41.83% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 395.66B |
| J. B. Chemicals & Pharmaceuticals | 333.73B |
| AstraZeneca Pharma India | 205.43B |
| Granules India | 173.27B |
| Jubilant Pharmova | 147.37B |
| Caplin Point Laboratories | 131.95B |
| CORONA Remedies | 105.60B |
| Viyash Scientific | 89.10B |